Microbiota and Glucidic Metabolism: A Link with Multiple Aspects and Perspectives

Area of Science:

• Microbiology
• Metabolic Health
• Gastroenterology

Background:

• Rising global rates of overweight and obesity present a significant socioeconomic challenge.
• The gut microbiota's role in metabolic disorders, including diabetes and obesity, is increasingly recognized.
• Chronic inflammation of adipose tissue is a key factor in glucose metabolism disorders and metabolic syndrome.

Purpose of the Study:

• To review clinical studies on the gut microbiota's impact on diabetic pathology.
• To elucidate the relationship between gut microbial composition and glucose metabolism disorders.
• To explore the potential for individualized therapies targeting the gut microbiota.

Main Methods:

• Narrative review of clinical studies.
• Analysis of research on gut microbiota composition and function.
• Examination of the link between microbial factors, obesity, and inflammation.

Main Results:

• Specific gut microbial compositions, particularly of a fermentative type, are associated with metabolic dysfunction.
• The gut microbiota significantly influences glucose tolerance.
• Evidence suggests a role for gut microbiota in the development of obesity and adipose tissue inflammation.

Conclusions:

• The gut microbiota is a critical factor in glucose tolerance and metabolic health.
• New insights into the gut microbiota offer potential for developing personalized treatments for insulin resistance and related conditions.
• Further research into gut microbiota modulation could lead to novel therapeutic strategies for metabolic syndrome.